Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Afrakoma Afriyie-Asante
Observed names:
A. Afriyie-Asante,,
Afrakoma AfriyieAsante,
Afriyie-Asante, Afrakoma
Institution:
University of Ottawa
Observed institutions:
University of Nottingham,
University of Ottawa,
Queen's University,
Ottawa Hospital,
Ottawa Hospital Research Institute
OpenAlex ID:
A5061098294
A selective PPM1A inhibitor activates autophagy to restrict the survival of Mycobacterium tuberculosis
2022
·
Stefania Berton
, Lu Chen
, et al.
·
Cell chemical biology
·
34
Mycobacterium tuberculosis Exploits Focal Adhesion Kinase to Induce Necrotic Cell Death and Inhibit Reactive Oxygen Species Production
2021
·
Afrakoma Afriyie-Asante
, Ankita Dabla
, et al.
·
Frontiers in Immunology
·
31
Prognostic significance of T cells, PD-L1 immune checkpoint and tumour associated macrophages in clear cell carcinoma of the ovary
2021
·
Rachel Sue-A-Quan
, Palak G. Patel
, et al.
·
Gynecologic Oncology
·
22
Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer
2023
·
Noor Shakfa
, Deyang Li
, et al.
·
Journal for ImmunoTherapy of Cancer
·
21
PDF
COVID-19 in Africa: an ovarian victory?
2021
·
Osman A. Dufailu
, Afrakoma Afriyie-Asante
, et al.
·
Journal of Ovarian Research
·
10
PDF
Environmental impact on postoperative wound infections in a privately owned hospital in Ghana
2014
·
P. Feglo,
, A. Afriyie-Asante,
·
African Journal of Microbiology Research
·
9
PDF
Multiple pathways of type 1 interferon production in lupus: the case for amlexanox
2020
·
Ian Todd
, Rhema E Thomas
, et al.
·
Lara D. Veeken
·
3
Chemotherapy induced immunogenic cell death alters response to exogenous activation of STING pathway and PD-L1 immune checkpoint blockade in a syngeneic murine model of ovarian cancer
2019
·
Sarah Nersesian
, Noor Shakfa
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
3
PDF
PTEN and BRCA1 tumor suppressor loss associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in a murine model of ovarian cancer
2022
·
Noor Shakfa
, Deyang Li
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Abstract 1708: Improving genotype specific chemotherapy response in ovarian cancer via cGAS-STING pathway activation
2021
·
Noor Shakfa
, Elizabeth Lightbody
, et al.
·
Cancer Research
·
1
STING pathway mediated immunologic consequences of DNA damage repair gene losses in high-grade serous ovarian tumors
2021
·
Noor E. Shakfa
, Elizabeth Lightbody
, et al.
·
The Journal of Immunology
STAT1 associated immune checkpoint expression and immune cell localization represent adaptive immune resistance in high-grade serous ovarian cancer
2021
·
Deyang Li
, Thiago Vidotto
, et al.
·
The Journal of Immunology
Abstract B78: Improving chemotherapy response of immunologically cold high-grade serous ovarian cancer with loss of PTEN using STING agonist
2020
·
Noor Shakfa
, Elizabeth Lightbody
, et al.
·
Clinical Cancer Research
STING pathway mediated immunologic consequences of DNA damage repair gene losses in high-grade serous ovarian tumors
2020
·
Noor E. Shakfa
, Elizabeth Lightbody
, et al.
·
The Journal of Immunology
Development and application of the antigen microarray for the detection of autoantibodies in hepatocellular carcinoma patients
2019
·
Afrakoma Afriyie-Asante
·
Nottingham ePrints (University of Nottingham)
Show more works
View as search
Works count:
16
Citation count:
135
H-index:
6
I10-index:
5
Year
Topic
Type
